A study to evaluate a mutation test (A test performed on the tumor block) in lung cancer patients who are taking gefitinib medicine.
Not Applicable
- Conditions
- Health Condition 1: null- Lung Cancer Patients
- Registration Number
- CTRI/2016/12/007575
- Lead Sponsor
- Dr Reddys Laboratory
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 200
Inclusion Criteria
Blocks of patients of Non-small cell lung cancer
Exclusion Criteria
Small cell lung cancer patients and any other cancer
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method